Abstract Title:

Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice.

Abstract Source:

Pediatr Nephrol. 2008 Aug;23(8):1287-91. Epub 2008 Apr 30. PMID: 18446380

Abstract Author(s):

Alper Soylu, Sema Berktaş, Sülen Sarioğlu, Güven Erbil, Osman Yilmaz, Belde K Demir, Yahya Tufan, Didem Yeşilirmak, Mehmet Türkmen, Salih Kavukçu

Abstract:

Immunoglobulin A nephropathy (IgAN) is associated with mucosal IgA defect. Probiotics regulate specific and innate immunity. We evaluated the effect of Saccharomyces boulardii on experimental IgAN in mice. Four groups of BALB/c mice (eight for each) were formed. Group 1 was immunized by oral poliovirus vaccine (OPV) at 0, 14, and 28 days. Group 2 was also given S. boulardii in addition to OPV. Group 3 was given only S. boulardii, whereas group 4 received no treatment. At week 6, after urine and serum samples were obtained for urinalysis and serum creatinine and IgA measurements, all animals were sacrificed to get their kidneys for histopathological evaluation. Urinalysis and serum creatinine levels were normal in all groups. Serum IgA level was increased only in group 1. Whereas group 1 had mesangial proliferation, histology was normal in the other groups. Predominant IgA deposition was universal in group 1, whereas it was either not present or minimal in other groups. Three mice in group 1 also had C3 deposition, which was absent in other groups. Electron microscopy revealed mesangial proliferation, matrix expansion, focal glomerular basement membrane thickening and electron-dense deposits in group 1 only, whereas the other groups were normal. In conclusion, enteral S. boulardii prevented OPV-induced IgAN in mice.

Pubmed Data : Pediatr Nephrol. 2008 Aug;23(8):1287-91. Epub 2008 Apr 30. PMID: 18446380
Study Type : Animal Study

Print Options

Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.

Post new comment

The content of this field is kept private and will not be shown publicly.
The subject field has a max length of 60 characters
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.